BUY-SIDE M&A

HGP begins each buy-side assignment with an intensive strategic review process designed to align the acquisition strategy with long-term shareholder objectives. Following completion of the initial strategic review, market assessment, and market mapping, HGP executes on the vision by identifying and pursuing acquisition targets. HGP dynamically reevaluates and refreshes the acquisition and strategic vision based on discovery from the process itself, which may be utilized to position a buyer for its own future liquidity event. Additionally, HGP offers Fairness Opinions to help satisfy the fiduciary duties placed on the board of the acquirer. HGP has experienced high success rates in identifying and closing proprietary transactions that achieve objectives of both the buyer and seller, resulting in strong returns for our clients.

HGP Buy-Side Advisory Process

Related Research & News Articles

HGP Advises Intelligent Medical Objects (IMO) in Acquisition of Melax Technologies

Read More

HGP Releases its January 2023 Annual Health IT Market Review

Read More

HGP Advises BloodHub in Sale to InVita Healthcare Technologies

Read More

HGP Advises Alivia Analytics in Platform Investment from Health Enterprise Partners and Council Capital

Read More